Evidence map›Paper›PMID 16131588›Full record

ArticleRNA (New York, N.Y.)2005

Direct selection of trans-acting ligase ribozymes by in vitro compartmentalization.

Matthew Levy, Karl E Griswold, Andrew D Ellington

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in RNA (New York, N.Y.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Pushing the Limits of Nucleic Acid Function.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Review
  3. Article
  4. Droplet Microfluidics and Directed Evolution of Enzymes: An Intertwined Journey.Angewandte Chemie (International ed. in English) · 2021
    Review
  5. Article
  6. Directed Evolution Methods for Enzyme Engineering.Molecules (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. A high-throughput screen for antibiotic drug discovery.Biotechnology and bioengineering · 2014 · on this map
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. DNA as a versatile chemical component for catalysis, encoding, and stereocontrol.Angewandte Chemie (International ed. in English) · 2010
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Matthew LevyInstitute for Cellular and Molecular Biology, University of Texas, Austin, TX 78751, USA.
Karl E Griswold
Andrew D Ellington
The University of Texas at Austin · USInstitut de Biologie Moléculaire et Cellulaire · FR

Funding

Ribozymes for Peptide- and Protein- Sensing Chip ArraysR01EB002043 · NIBIB · UNIVERSITY OF TEXAS AUSTIN · PI ELLINGTON, ANDREW D · 2003 to 2004
$461k
NIBIB NIH HHS 8R01 EB002043NIBIB NIH HHS R01 EB002043
6 · The paper itself

Abstract

We have used a compartmentalized in vitro selection method to directly select for ligase ribozymes that are capable of acting on and turning over separable oligonucleotide substrates. Starting from a degenerate pool, we selected a trans-acting variant of the Bartel class I ligase which statistically may have been the only active variant in the starting pool. The isolation of this sequence from the population suggests that this selection method is extremely robust at selecting optimal ribozymes and should, therefore, prove useful for the selection and optimization of other trans-acting nucleic acid catalysts capable of multiple turnover catalysis.

Indexed as

Base PairingBase SequenceCloning, MolecularDNAEmulsionsFlow CytometryFluoresceinFluorescent DyesGenetic VariationHydrazinesIn Vitro TechniquesKineticsLigasesMicrospheresModels, ChemicalNucleic Acid Amplification TechniquesAlexa 488 hydrazideDNAEmulsionsFluoresceinFluorescent DyesHydrazinesLigasesRNA, Catalytic

Identifiers

PMID16131588
PMCPMC1370839
OpenAlexW2004821539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.